Sector: MedicalMIPI (NASDAQ: MIPI)
Headlines
- Molecular Insight Pharmaceuticals Announces Changes to Board
Nov 24, 2009 04:01 PM | MIPI
- Molecular Insight Pharmaceuticals to Present at Lazard Capital Markets Annual Healthcare Conference
Nov 11, 2009 03:14 PM | MIPI
- Molecular Insight Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 09, 2009 04:02 PM | MIPI
- Molecular Insight Pharmaceuticals, Inc. to Report Third Quarter Financial Results on November 9, 2009
Oct 26, 2009 08:30 AM | MIPI
- Molecular Insight Pharmaceuticals Finalizes Onalta(TM) Manufacturing and Supply Agreements
Oct 21, 2009 08:30 AM | MIPI
- Molecular Insight Pharmaceuticals Presents Azedra(TM) 12-Month Efficacy Data From Phase I Clinical Trial in Neuroendocrine Tumors
Oct 05, 2009 08:35 AM | MIPI
- Molecular Insight Pharmaceuticals, Inc. to Present at Rodman and Renshaw 11th Annual Healthcare Conference
Sep 04, 2009 10:13 AM | MIPI
- Molecular Insight Pharmaceuticals, Inc. Sub-Licenses Onalta(TM) for Development
Sep 02, 2009 04:34 PM | MIPI, NVS
- Molecular Insight Pharmaceuticals Files Universal Shelf Registration Statement
Aug 28, 2009 05:11 PM | MIPI
- FDA, Clinical Trial Calendar Updates
May 11, 2009 05:14 PM | AZN, IMGN, MELA, MIPI
- Molecular Insight Pharmaceuticals Reports Inducement Grant for CEO Under NASDAQ Marketplace Rule 4350
Aug 11, 2009 05:06 PM | MIPI
- Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial and Operational Results
Aug 10, 2009 07:51 AM | MIPI, PFE
- Molecular Insight Pharmaceuticals, Inc. Advances Azedra Program Into Pivotal Phase 2 Therapeutic Trial in Neuroendocrine Cancer Patients
Aug 07, 2009 09:08 AM | MIPI
- Molecular Insight Pharmaceuticals, Inc. Appoints Charles H. Abdalian, Jr. Vice President of Finance, CFO
Aug 05, 2009 10:04 AM | EMIS, MIPI
- Molecular Insight Pharmaceuticals, Inc. to Announce Second Quarter Financial Results on August 10, 2009
Jul 27, 2009 04:10 PM | MIPI
- Alert on Wall Street Movers - Research in Motion, Smith & Wesson, Century Aluminum, Molecular Insight, RF Micro, A-Power Energy; Research by InvestorSoup.com
Jun 19, 2009 09:20 AM | APWR, CENX, MIPI, RFMD, RIMM, SWHC
- Molecular Insight Pharmaceuticals, Inc. Presents Clinical Data on Prostate Cancer Diagnostic
Jun 16, 2009 04:35 PM | MIPI
- Molecular Insight Pharmaceuticals, Inc. to Present at Jefferies Healthcare Conference
Jun 11, 2009 05:31 PM | MIPI
- Molecular Insight Pharmaceuticals, Inc. to Present Clinical, Preclinical Data at the Society of Nuclear Medicine 2009 Annual Meeting
Jun 10, 2009 12:44 PM | MIPI
- Molecular Insight Pharmaceuticals, Inc. Receives European Medicines Agency Approval to Proceed With Phase 3 Development of Onalta(TM)
May 14, 2009 07:30 AM | MIPI
- Form 4 Molecular Insight Pharma For: Nov 17 Filed by: Abdalian Charles H Jr (10K)
Nov 18, 2009 10:39 PM
- Form 4 PETERS DANIEL For: Aug 11 (10K)
Aug 13, 2009 09:47 AM
- Form 4 Babich John W For: Aug 11 (10K)
Aug 12, 2009 11:33 PM
- Form 4 Abdalian Charles H Jr For: Aug 11 (10K)
Aug 12, 2009 11:30 PM
- Form 3 Abdalian Charles H Jr For: Aug 10 (10K)
Aug 12, 2009 11:28 PM
- Form 3 PETERS DANIEL For: May 26 (10K)
Jun 05, 2009 02:40 PM
- Form 4 Gottlieb Scott For: May 29 (10K)
Jun 01, 2009 04:49 PM
- Form 4 LaFrance Norman D. For: May 28 (10K)
May 29, 2009 05:48 PM
- Form 4 Wallroth Donald E. For: May 22 (10K)
May 26, 2009 11:10 PM
- Form 4/A Kronauge James F For: May 12 (10K)
May 14, 2009 08:08 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MIPI
|
Compare to S&P
|
| YTD |
-15.35 %
|
-29.95 %
|
| 4 Weeks |
-24.17 %
|
-28.01 %
|
| 12 Weeks |
-31.58 %
|
-36.29 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -28.79 %
|
|
EPS Growth in Last Year: 14.14 %
|
|
Sales Growth in Last Quarter: -26.28 %
|
|
Sales Growth in Last Quarter: 62.90 %
|
|
